BridgeBio Pharma, Inc. (2CL)
Market Open
19 Dec, 14:44
XFRA 
€
64. 16
+1.34
+2.13%
€
- Market Cap
- P/E Ratio
0% Div Yield
0 Volume
-3.85 Eps
€ 62.82
Previous Close Day Range
63.02 64.16
Year Range
24.53 64.2
Want to track 2CL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 62 days
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
 BBIO BridgeBio Pharma Inc. 19 Feb 2026 (In 2 months) | | - | - |
| BBIO BridgeBio Pharma Inc. 11 Nov 2025 | | - | - |
| BBIO BridgeBio Pharma Inc. 30 Oct 2025 | | - | - |
| BBIO BridgeBio Pharma Inc. 31 Jul 2025 | | - | - |
| BBIO BridgeBio Pharma Inc. 30 Apr 2025 | | - | - |
| BBIO BridgeBio Pharma Inc. 20 Feb 2025 | | - | - |
| BBIO BridgeBio Pharma Inc. 31 Oct 2024 | | - | - |
| BBIO BridgeBio Pharma Inc. 1 Aug 2024 | | - | - |
| BBIO BridgeBio Pharma Inc. 2 May 2024 | | - | - |
| BBIO BridgeBio Pharma Inc. 21 Feb 2024 | | - | - |
| BBIO BridgeBio Pharma Inc. 1 Nov 2023 | | - | - |
2CL Earnings Reports FAQ
What is the earnings per share (EPS) for 2CL?
The current EPS is -3.85.
What is the company's earnings growth rate?
BridgeBio Pharma, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
The next earnings release is expected to be on 2026-02-19, based on the 2CL's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings for BridgeBio Pharma, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 2CL at this time, as BridgeBio Pharma, Inc has no recent EPS data to calculate it.
